Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

NCT04171492

This study evaluates the how addition of the Nodify XL2 test result impacts the clinical management of newly identified solid lung nodules assessed as low to moderate risk of cancer.

Nodule Solitary PulmonaryNon-small Cell Carcinoma

Biodesix, Inc.2,000 participantsStarted Dec 2020

Aurora, Colorado, United States • Boston, Connecticut, United States • Boston, Connecticut, United States +22 more locations

WITHDRAWNNA

Expressions of TRPV1 in Airway of Asthmatics

NCT02952066

The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.

Moderate Persistent AsthmaSevere Persistent AsthmaNodule Solitary Pulmonary+1 more

Lu Yuan LeeStarted Sep 2017

Lexington, Kentucky, United States

Data from ClinicalTrials.govTerms

Filters

Filters

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Expressions of TRPV1 in Airway of Asthmatics

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Expressions of TRPV1 in Airway of Asthmatics